hemagglutinating < hemagglutination < hemagglutinin

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000027 (1984)	A. Yamada [États-Unis] ; L. E. Brown [États-Unis] ; R. G. Webster [États-Unis]	Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: Influence of receptor specificity
000036 (2002)	N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne]	Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
000049 (1984)	K. Nerome [Japon] ; Y. Yoshioka [Japon] ; C. A. Torres [Japon] ; A. Oya [Japon] ; P. Bachmann [Allemagne] ; K. Ottis [Allemagne] ; R. G. Webster [États-Unis]	Persistence of Q strain of H2N2 influenza virus in avian species: Antigenic, biological and genetic analysis of avian and human H2N2 viruses
000052 (1980)	R. A. Heijtink [Pays-Bas] ; N. Masurel [Pays-Bas] ; W. Weimar [Pays-Bas] ; S. W. Schalm [Pays-Bas]	Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon
000066 (1982)	R. G. Webster [États-Unis] ; V. S. Hinshaw [États-Unis] ; W. G. Laver [États-Unis]	Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies
000082 (1973)	N. Masurel [Pays-Bas] ; A. J. Baars [Pays-Bas] ; Henny Frankena [Pays-Bas]	Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus
000122 (1980)	Ann H. Erickson [États-Unis] ; Edwin D. Kilbourne [États-Unis]	Mutation in the hemagglutinin of A/N-WS/33 influenza virus recombinants influencing sensitivity to trypsin and antigenic reactivity
000195 (2012)	Yoshihiro Sakoda ; Masatoshi Okamatsu ; Norikazu Isoda ; Naoki Yamamoto ; Koichi Ozaki ; Yasuto Umeda ; Shigeyuki Aoyama ; Hiroshi Kida [Japon]	Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) in the process of vaccine production
000225 (1976)	J. Drescher [Allemagne] ; U. Desselberger [Allemagne]	Kinetics of reactions of antihemagglutinin and antineuraminidase antibodies with H2N2 and H3N2 influenza virus strains and description of a modification of the photometric ACU method for titration of antineuraminidase antibodies
000257 (1984)	R. G. Webster [États-Unis] ; L. E. Brown [États-Unis] ; W. G. Laver [États-Unis]	Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies
000277 (1973)	Th. C. O'Brien [États-Unis] ; Nicola M. Tauraso [États-Unis]	Antibodies to type A influenza viruses in sera from nonhuman primates
000344 (1992)	Nobutaka Wakamiya [Japon] ; Yoshinobu Okuno [Japon] ; Fuyoko Sasao [Japon] ; Shigeharu Ueda [Japon] ; Kumiko Yoshimatsu [Japon] ; Masaharu Naiki [Japon] ; Takashi Kurimura [Japon]	Isolation and characterization of conglutinin as an influenza A virus inhibitor
000397 (1981)	John M. Quarles [États-Unis] ; Robert B. Couch [États-Unis] ; Thomas R. Cate [États-Unis] ; Claude B. Goswick [États-Unis]	Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza
000466 (2012)	R. Allwinn [Allemagne] ; M. Bickel [Allemagne] ; C. Lassmann [Allemagne] ; S. Wicker [Allemagne] ; I. Friedrichs [Allemagne]	“Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?”
000470 (1980)	G. C Schild [Royaume-Uni] ; R. W Newman [Royaume-Uni] ; R. G Webster [États-Unis] ; Diane Major [Royaume-Uni] ; Virginia S. Hinshaw [États-Unis]	Antigenic analysis of influenza a virus surface antigens: Considerations for the nomenclature of influenza virus
000485 (1995)	Seema Abbasi [États-Unis] ; William Gruber [États-Unis] ; Kathryn Edwards [États-Unis] ; Larisa Gubareva [États-Unis] ; Robert G. Webster [États-Unis] ; Yoshihiro Kawaoka [États-Unis]	The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees
000495 (1975)	Robert G. Webster [États-Unis] ; W. G. Laver [Australie] ; Bela Tumova [Tchécoslovaquie]	Studies on the origin of pandemic influenza viruses
000520 (1978)	Ch. Kunz [Autriche] ; H. Hofmann [Autriche] ; A. Moritz [Autriche] ; H. Bachmayer [Autriche] ; E. Liehl [Autriche]	Eine neue Influenza Subunit Vakzine: Hämagglutinations-hemmende Antikörper ein Jahr nach der Impfung
000530 (1990)	L. A. White [États-Unis] ; C. Y. Freeman [États-Unis] ; H. E. Hall [États-Unis] ; B. D. Forrester [États-Unis]	Inactivation and stability of viral diagnostic reagents treated by gamma radiation
000531 (1990)	Paul A. Rota [États-Unis] ; Barun K. De [États-Unis] ; Michael W. Shaw [États-Unis] ; Renee A. Black [États-Unis] ; William C. Gamble [États-Unis] ; Alan P. Kendal [États-Unis]	Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model
000569 (2008)	Julian W. Tang [République populaire de Chine] ; Karry L. K. Ngai [République populaire de Chine] ; Paul K. S. Chan [République populaire de Chine, Hong Kong]	Lack of cross‐immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "hemagglutination" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "hemagglutination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    hemagglutination
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021